Altamira Therapeutics CYTOF Ratios (2013-2025)

OTC CYTOF
$0.07 +0.00 (+0.00%)
At close: Nov 13, 2026 · 4:00 PM EST
Reported Financials

Altamira Therapeutics Quarterly Ratios

Periods 36 quarters
Latest Jun 2025

Altamira Therapeutics ratios data for the quarter ended Jun 2025. These financial ratios cover 36 quarters of results from Jun 2013 through Jun 2025, standardized by Business Quant from the company’s SEC filings.

RatiosRatios Jun2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Jun2019 Dec2019 Jun2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Jan2023 Jun2023 Dec2023 Jun2024 Dec2024 Jun2025
Profitability
EBT Margin
-1,482.46%-1,183.51%-515.11%-612.07%
EBIT Margin
-1,368.42%-1,405.65%-1,263.82%-616.99%
EBITDA Margin
-1,360.78%-1,398.73%-1,256.94%-612.46%
Operating Margin
-1,368.42%-1,405.65%-1,263.82%-616.99%
Net Margin
-1,458.32%-1,213.94%-425.65%-457.70%
FCF Margin
-1,172.54%-1,666.75%-1,462.66%-456.63%
Efficiency
Inventory AverageInventory Avg.
0.57M0.54M0.08M0.01M0.16M
Assets AverageAssets Avg.
71.43M65.32M17.37M12.00M7.86M9.14M11.03M10.77M8.95M15.98M24.68M23.38M20.17M13.10M6.82M6.86M8.01M8.60M8.36M7.89M
Equity AverageEquity Avg.
52.38M48.48M-1.84M-2.52M-2.16M1.48M6.44M7.70M5.47M11.87M20.42M18.04M10.67M-0.97M-9.00M-5.51M2.81M6.99M6.44M5.32M
Invested CapitalInvested Cap.
104.45M8.14M3.14M5.17M4.76M19.62M14.39M11.99M-2.38M-2.64M1.38M12.95M6.44M6.69M4.52M
Asset Utilization RatioAsset Util.
0.020.020.090.14
Leverage & Solvency
Interest Coverage RatioInterest Cover
-13.33-13.87-12.33-6.14-23.30-7.36
Debt Ratio
0.050.570.280.150.010.030.010.250.970.930.490.010.020.010.06
Times Interest Earned
-13.33-13.87-12.33-6.14-23.30-7.36
Valuation
Price to BookP/B
1.070.820.830.981.901.030.220.090.080.08
Enterprise Value
5.25M3.81M2.99M12.28M26.08M6.87M5.71M5.71M-28.22M0.98M0.48M-0.49M0.32M
Market Capitalization
6.68M3.85M15.76M21.47M27.16M7.26M5.72M5.72M0.76M1.71M0.55M0.51M0.33M
Return Ratios
Return on Sales [ROS]ROS
-1,368.42%-1,405.65%-1,263.82%-616.99%
Return on Capital Employed [ROCE]ROCE
-38.80%-45.21%-310.41%-751.18%-1,610.30%-250.70%
Return on Invested Capital [ROIC]ROIC
-43.04%-43.84%-387.19%
Return on Assets [ROA]ROA
-35.95%-37.90%-104.97%-132.20%-160.82%-128.07%
Return on Equity [ROE]ROE
-49.02%-51.06%-793.16%

Altamira Therapeutics Ratios API

Pull Altamira Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CYTOF&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY